(IN BRIEF) AstraZeneca’s Alexion has secured European Commission approval for Koselugo (selumetinib), the first targeted therapy available to adults with…
(IN BRIEF) The Port of Rotterdam Authority has launched its Nature Vision 2025–2050, outlining a roadmap for integrating ecological restoration…
(IN BRIEF) Digi Communications N.V. announced that its Romanian subsidiary, Digi Romania S.A., has successfully completed the €600 million offering…
(IN BRIEF) Stadler has received an order from the Utah Transit Authority (UTA) for 20 additional Citylink light rail vehicles,…
(IN BRIEF) GSK announced that its B7-H3-targeted antibody-drug conjugate GSK5764227 (GSK’227) has been granted Orphan Drug Designation (ODD) by the…
(IN BRIEF) GSK has signed an exclusive global licensing agreement with Empirico Inc. for EMP-012, a first-in-class siRNA candidate currently…
(IN BRIEF) Roche announced that its Phase III INShore trial evaluating Gazyva/Gazyvaro (obinutuzumab) in children and young adults with idiopathic…
(IN BRIEF) TÜV Rheinland Hong Kong has received the CLP Smart Energy Award 2025 – Sustainable Carbon Neutral Award (Industrial)…
(IN BRIEF) Thales has received a contract from France’s Defence Procurement Agency (DGA) to develop AURORE, a new low Earth…
(IN BRIEF) E.ON SE has signed a major strategic contract with Nokia to build Germany’s first high-efficiency telecommunications network for…